4.1 Article

Conference proceedings from the 23rd Bangkok International Symposium on HIV Medicine

Journal

FUTURE VIROLOGY
Volume 16, Issue 4, Pages -

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/fvl-2021-0029

Keywords

antiretroviral therapy (ART) • children living with HIV; COVID-19; HIV prevention and care; integrated services delivery; key population led health services; latent tuberculosis; TB vaccine

Categories

Funding

  1. Thailand Convention and Exhibition Bureau (TCEB)
  2. ViiV Healthcare
  3. GSK ViiV
  4. Sysmex Corporation
  5. Gilead Sciences
  6. Atlanta
  7. CAMBER
  8. Cepheid
  9. Oxford Immunotec
  10. The Government Pharmaceutical Organization (GPO)
  11. TREAT Asia
  12. VIATRIS \ Mylan + Upjohn
  13. Second Century Fund (C2F), Chulalongkorn University

Ask authors/readers for more resources

The Bangkok International Symposium on HIV Medicine is the longest running HIV conference in the Asia-Pacific region, which was held virtually for the first time due to COVID-19 pandemic. Over 1800 healthcare professionals from 41 countries attended the symposium. The sessions covered topics on COVID-19, the WHO's vision for integrating HIV care delivery models, and innovative models developed by physicians in their clinics.
The Bangkok International Symposium on HIV Medicine is the longest running HIV conference in the Asia-Pacific, that provides professional healthcare workers with the latest information on HIV and related fields. For the first time, this event was held as a virtual symposium due to the COVID-19 pandemic and registration was free to everyone. More than 1800 people viewed the symposium from 41 countries. The first sessions reviewed COVID-19 and had a panel representing physicians from Australia, Myanmar, Indonesia and Thailand, who shared experiences in managing HIV care during the pandemic. For the first time, we had sessions on the WHO's vision for integrating HIV care delivery models, and a number of physicians shared the innovative models that have been developed in their clinics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available